JVMAX | TCMVX | JVMAX / TCMVX | |
Total Expense Ratio | 1.12 | 0.81 | 138% |
Annual Report Gross Expense Ratio | 1.13 | 0.81 | 140% |
Fund Existence | 28 years | 23 years | - |
Gain YTD | 8.143 | 3.759 | 217% |
Front Load | 5% | 6% | 87% |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.6B | 1.67B | 1,357% |
Annual Yield % from dividends | 0.58 | 1.40 | 41% |
Returns for 1 year | 2.13 | 4.03 | 53% |
Returns for 3 years | 22.68 | 14.36 | 158% |
Returns for 5 years | 61.48 | 40.00 | 154% |
Returns for 10 years | 40.93 | -22.09 | -185% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BMED | 25.43 | 0.58 | +2.35% |
iShares Health Innovation Active ETF | |||
VNQ | 89.75 | 0.56 | +0.63% |
Vanguard Real Estate ETF | |||
ISPY | 42.77 | 0.13 | +0.30% |
ProShares S&P 500 High Income ETF | |||
MLPR | 60.50 | 0.04 | +0.06% |
ETRACS Qrtly Py 1.5X Lvgd Aln MLP ETN | |||
NHS | 7.55 | -0.04 | -0.53% |
Neuberger Berman High Yield Strategies Fund |